Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg (Blend)
$125.00
PRODUCT SHORT DESCRIPTION
Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg Blend from USA PEPTIDE SCIENCES is a sophisticated triple-peptide research formulation combining two complementary GHRH analogs with a highly selective ghrelin receptor agonist for comprehensive, multi-pathway somatotropic axis investigation. This advanced blend enables investigators to study the convergent and additive effects of dual GHRH receptor engagement alongside GHS-R1a activation — modeling amplified GH pulsatility, downstream IGF-1 dynamics, and associated metabolic parameters within a single analytically verified research platform. Every batch is HPLC-MS verified to ≥99% purity and accompanied by a full Certificate of Analysis.
The Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg Blend is a precision-formulated, triple-peptide research compound available exclusively at The Peptide Store, manufactured to a minimum purity of ≥98% and verified by independent analytical testing. This advanced somatotropic research blend integrates two structurally distinct GHRH receptor agonists alongside a highly selective ghrelin receptor agonist into a single, cohesive research formulation. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Product Overview
The Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg Blend represents one of the most compositionally sophisticated growth hormone secretagogue research formulations currently available for laboratory investigation. Designed for qualified researchers studying the somatotropic axis, this triple-peptide architecture enables comprehensive, multi-pathway investigation of GH secretory regulation. By combining two complementary GHRH analogs with a benchmark ghrelin receptor agonist, this blend offers an unparalleled platform for studying convergent and additive signaling mechanisms at the anterior pituitary level. Available to buy online from The Peptide Store with fast, reliable fulfillment.
Peptide Structure & Amino Acid Sequence
This blend incorporates three independently characterized peptide compounds, each contributing a distinct receptor-binding profile:
- Tesamorelin — A synthetic analog of endogenous growth hormone-releasing hormone (GHRH), retaining the full 44-amino acid sequence of native GHRH with a trans-3-hexenoic acid modification at the N-terminus, conferring enhanced stability and receptor affinity.
- CJC-1295 (No DAC) — A truncated, modified GHRH analog comprising a 30-amino acid sequence with strategic substitutions that improve metabolic resistance while maintaining potent GHRH receptor agonism. The absence of the Drug Affinity Complex (DAC) component results in a shorter half-life profile, making it suitable for pulsatile secretion research models.
- Ipamorelin — A pentapeptide ghrelin receptor (GHS-R1a) agonist with exceptional selectivity, characterized by its minimal off-target activity on cortisol, prolactin, and ACTH pathways, making it a preferred GHS tool compound in somatotropic research.
Chemical & Physical Characteristics
Each peptide component within this blend has been precisely measured and combined to deliver a consistent, reproducible research formulation. The lyophilized powder presents as a white to off-white solid with characteristic hygroscopic properties. The blend is water-soluble and compatible with standard aqueous reconstitution buffers used in laboratory settings. Molecular weights, isoelectric points, and solubility profiles for each component are available upon request through The Peptide Store’s documentation support.
Purity & Analytical Verification (HPLC & MS)
All peptide components within this blend are independently verified to ≥98% purity prior to formulation. The Peptide Store applies rigorous analytical protocols including:
- High-Performance Liquid Chromatography (HPLC) — Confirms purity levels and detects any residual synthesis by-products or impurities across all three peptide components.
- Mass Spectrometry (MS) — Validates the molecular identity and structural integrity of Tesamorelin, CJC-1295 (No DAC), and Ipamorelin individually before blending.
- Certificate of Analysis (CoA) — Available for each batch, documenting purity, identity confirmation, and analytical methodology.
Quality Control & Lyophilization Integrity
The blended formulation undergoes lyophilization under controlled pharmaceutical-grade conditions to ensure uniform distribution of all three peptide components throughout the final powder matrix. Lyophilization preserves the structural integrity and bioactivity potential of each peptide for research purposes, minimizing degradation risks associated with liquid formulations. Batch-level quality control records are maintained and traceable, ensuring consistency across every unit available for sale at The Peptide Store.
Safety, Handling & Laboratory Precautions
This research compound must be handled exclusively by trained laboratory professionals in appropriately equipped research environments. Standard laboratory personal protective equipment (PPE), including gloves, lab coat, and eye protection, should be worn at all times when handling this material. The compound should not be inhaled, ingested, or brought into contact with skin or mucous membranes. All handling, storage, and disposal must comply with applicable institutional biosafety protocols and local regulatory requirements governing research peptides.
Reconstitution, Packaging & Storage
The Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg Blend is supplied as a lyophilized powder in a sealed, sterile vial suitable for laboratory reconstitution using standard aqueous research buffers. Reconstitution is intended solely for in vitro or approved preclinical research applications. Recommended storage conditions are as follows:
- Long-term storage: −20°C in a frost-free freezer, protected from light and moisture.
- Short-term storage: 2–8°C (refrigerated) for periods not exceeding 4 weeks post-reconstitution.
- Avoid repeated freeze-thaw cycles to preserve peptide integrity.
Intended Research Use & Market Positioning
This triple-peptide blend is specifically positioned for advanced somatotropic axis research, enabling investigators to explore the convergent effects of dual GHRH receptor engagement alongside GHS-R1a activation. It is particularly well-suited for in vitro cell-based assays, receptor binding studies, and preclinical models evaluating multi-pathway GH secretory regulation. The Peptide Store offers this formulation as a premium, high-purity research tool compound for academic, institutional, and pharmaceutical research teams seeking the most compositionally advanced GH secretagogue blend currently available to order.
Ordering, Availability & Fulfillment
The Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg Blend is available to buy online directly from The Peptide Store at a competitive best price, with secure checkout and prompt dispatch. We maintain consistent stock levels and offer reliable domestic and international shipping to qualified research institutions. Order now to take advantage of our streamlined fulfillment process and dedicated customer support team.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. The Tesamorelin, CJC-1295 (No DAC), Ipamorelin 12mg Blend is sold exclusively as a laboratory research compound. The Peptide Store makes no claims regarding therapeutic efficacy, safety for human administration, or suitability for any use beyond qualified scientific research. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international laws and regulations governing the acquisition, possession, and use of research peptides.
Related products
GHRP-2 (5mg x 10) Ipamorelin (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and Ipamorelin combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-2 alongside ten 5mg vials of Ipamorelin. This 5000mcg per vial configuration is engineered strictly for investigating ghrelin receptor subtype mechanics, comparative GHS-R1a agonist kinetics, and amplified growth hormone (GH) secretion profiles.
GHRP-2 (5mg x 5) and Ipamorelin (5mg x 5)
PRODUCT SHORT DESCRIPTION
The GHRP-2 and Ipamorelin combination platform delivers a high-resolution, multi-vial research kit containing five 5mg vials of GHRP-2 alongside five 5mg vials of Ipamorelin. This 5000mcg per vial configuration is engineered strictly for investigating ghrelin receptor subtype mechanics, comparative GHS-R1a agonist kinetics, and amplified growth hormone (GH) secretion profiles.
GHRP-6 (5mg x 10) Ipamorelin (5mg x 10)
PRODUCT SHORT DESCRIPTION
The GHRP-6 and Ipamorelin combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of GHRP-6 alongside ten 5mg vials of Ipamorelin. This 5000mcg per vial configuration is engineered strictly for investigating ghrelin receptor subtype mechanics, comparative GHS-R1a agonist kinetics, and amplified growth hormone (GH) secretion profiles.
GHRP-6 10mg
PRODUCT SHORT DESCRIPTION
GHRP-6 10mg is a premium, high-purity synthetic hexapeptide engineered for advanced somatotropic and metabolic axis evaluation. This 10mg formulation provides a highly potent biochemical tool for investigating GHS-R1a receptor kinetics, intracellular signaling mechanisms, and pulsatile growth hormone (GH) transcription.
Hexarelin (5mg x 10), CJC-1295 no DAC (5mg x 10)
PRODUCT SHORT DESCRIPTION
The Hexarelin and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 5mg vials of Hexarelin alongside ten 5mg vials of CJC-1295 No DAC. This 5000mcg per vial configuration is engineered strictly for investigating dual-receptor somatotroph coordination, maximum growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.
hGH Fragment 176-191 6mg
PRODUCT SHORT DESCRIPTION
hGH Fragment 176–191 6mg is a premium, high-purity synthetic 15-amino-acid peptide mimicking the localized C-terminal domain of human growth hormone. This 6000mcg configuration provides an isolated biochemical tool for investigating adipocyte lipolysis and lipid oxidation pathways without inducing somatotropic growth or elevating systemic IGF-1 profiles.
IGF-1 LR3 1mg
PRODUCT SHORT DESCRIPTION
IGF-1 LR3 1mg is a premium, high-potency synthetic 83-amino-acid analog of human Insulin-like Growth Factor-1. Featuring an arginine substitution at position 3 and a 13-amino-acid N-terminal extension, this 1000mcg configuration is engineered strictly for investigating sustained somatotropic signaling and uninhibited receptor binding kinetics.
Ipamorelin (2mg x 10), CJC-1295 no DAC (2mg x 10)
PRODUCT SHORT DESCRIPTION
The Ipamorelin and CJC-1295 No DAC combination platform delivers a high-resolution, multi-vial research kit containing ten 2mg vials of Ipamorelin alongside ten 2mg vials of CJC-1295 No DAC. This configuration is engineered strictly for investigating dual-receptor somatotroph coordination, amplified growth hormone (GH) pulsatility, and downstream endocrine signaling kinetics.

Reviews
There are no reviews yet.